International Journal of Drug Policy
Volume 21, Issue 4 , Pages 296-301, July 2010

Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003☆☆☆

  • Michael Martin

      Affiliations

    • Thailand Ministry of Public Health—U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States
    • Corresponding Author InformationCorresponding author at: DDC 7 Building, 4th Floor, Ministry of Public Health, Soi 4, Nonthaburi 11000, Thailand. Tel.: +66 2 580 0669; fax: +66 2 580 0712.
    • ,
  • Suphak Vanichseni

      Affiliations

    • Bangkok Vaccine Evaluation Group, Bangkok, Thailand
    • ,
  • Pravan Suntharasamai

      Affiliations

    • Mahidol University, Bangkok, Thailand
    • ,
  • Philip A. Mock

      Affiliations

    • Thailand Ministry of Public Health—U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • ,
  • Frits van Griensven

      Affiliations

    • Thailand Ministry of Public Health—U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States
    • ,
  • Punnee Pitisuttithum

      Affiliations

    • Mahidol University, Bangkok, Thailand
    • ,
  • Jordan W. Tappero

      Affiliations

    • Thailand Ministry of Public Health—U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    • Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, GA, United States
    • ,
  • Sithisat Chiamwongpaet

      Affiliations

    • Bangkok Metropolitan Administration, Bangkok, Thailand
    • ,
  • Udomsak Sangkum

      Affiliations

    • Bangkok Metropolitan Administration, Bangkok, Thailand
    • ,
  • Dwip Kitayaporn

      Affiliations

    • Mahidol University, Bangkok, Thailand
    • Bumrungrad International Hospital, Bangkok, Thailand
    • ,
  • Marc Gurwith

      Affiliations

    • VaxGen, Inc., Brisbane, CA, United States
    • ,
  • Kachit Choopanya

      Affiliations

    • Bangkok Vaccine Evaluation Group, Bangkok, Thailand
    • ,
  • for the Bangkok Vaccine Evaluation Group

      Affiliations

    • The Bangkok Vaccine Evaluation Group—Kachit Choopanya (Principal Investigator), Suphak Vanichseni; The Bangkok Metropolitan Administration (BMA) Department of Health—Sithisat Chiamwongpaet, Wuwanee Raktham, Boonrawd Prasittipol, La-Ong Srisuwanvilai, Kovit Yongvanitjit; BMA Department of Medical Services—Wonchat Subhachaturas, Udomsak Sangkum; Mahidol University—Valai Bussaratid, Jaranit Kaewkungwal, Dwip Kitayaporn, Sricharoen Migasena, Benjaluck Phonrat, Punnee Pitisuttithum, Sawangjai Pungpak, Pravan Suntharasamai; The Thailand Ministry of Public Health—U.S. Centers for Disease Control and Prevention Collaboration—Thanyanan Chaowanachan, Thitima Cherdtrakulkiat, Wanitchaya Kittikraisak, Wanna Leelawiwat, Michael Martin, Janet McNicholl, Supawadee Na-Pompet, Chalintorn Sinthuwattanawibul, Jordan W. Tappero, Frits van Griensven, Punneeporn Wasinrapee, Nancy Young; The U.S. Centers for Disease Control and Prevention—Dale Hu, Timothy D. Mastro; VaxGen, Inc.—Phillip Berman, Lisa Brooks, Marlene Chernow, Don Francis, Carolyn Gee, Marc Gurwith, William Heyward, Tina Ippolito, David Jobes, Tina Kalanon, Elizabeth Li, Aimee Luck, Karin Orelind, Patti Orozco-Cronin, Michael L. Peterson, Faruk Sinangil.

Received 8 October 2009; received in revised form 8 December 2009; accepted 15 December 2009. published online 15 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Clinical trial registration: The AIDSVAX B/E HIV vaccine trial is registered at ClinicalTrials.gov http://clinicaltrials.gov/ct2/show/NCT00006327?term=AIDSVAX&rank=6 ClinicalTrials.gov Identifier: NCT00006327.

☆☆ Disclaimer: The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the U.S. Centers for Disease Control and Prevention.

PII: S0955-3959(09)00163-7

doi:10.1016/j.drugpo.2009.12.002

International Journal of Drug Policy
Volume 21, Issue 4 , Pages 296-301, July 2010

Article Tools